Pharmacologic Treatment Strategies in Psoriatic Arthritis
- 15 July 2023
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 45 (9) , 826-840
Abstract
No abstract availableKeywords
This publication has 144 references indexed in Scilit:
- Tumor Necrosis Factor Inhibitors for Inflammatory Bowel DiseaseNew England Journal of Medicine, 2013
- Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trialThe Lancet, 2013
- High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnairesAnnals of the Rheumatic Diseases, 2013
- Secukinumab in the Treatment of Noninfectious Uveitis: Results of Three Randomized, Controlled Clinical TrialsOphthalmology, 2013
- High Frequency of Fibromyalgia in Patients with Psoriatic Arthritis: A Pilot StudyArthritis, 2013
- A randomized placebo-controlled trial of methotrexate in psoriatic arthritisRheumatology, 2012
- Discovery and mechanism of ustekinumabmAbs, 2011
- Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohortArthritis Care & Research, 2010
- Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatmentAnnals of the Rheumatic Diseases, 2010
- Abatacept in the treatment of rheumatoid arthritisArthritis Research & Therapy, 2008